Trial intelligence / Profile preview

High-dose acyclovir vs. valacyclovir for HSV-2 shedding

NCT00362297Phase 4Completed

Sponsor
University of Washington
Start
Sep 2006
Primary completion
Dec 2008
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of aciclovir in genital herpes, sponsored by University of Washington. Started Sep 2006; status: completed.

02

Drugs

aciclovir
03

Conditions

genital herpes

Beyond the preview

Go deeper on NCT00362297.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00362297.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call